proxyvotesnow.com

Home › Companies › Utah Medical Products, Inc. › 2024-2025

Utah Medical Products, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated 02 October 2026.

  • 6Reported items
  • 154Asset managers
  • 596Fund votes
  • 2025-05-02Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Utah Medical Products, Inc. in the interactive database Compare manager voting policies

How asset managers voted at the Utah Medical Products, Inc. 2024-2025 meeting

Each item below shows how the 154 asset managers that disclosed a Utah Medical Products, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Utah Medical Products, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, by advisory vote, the Company's executive compensation program.

SECTION 14A SAY-ON-PAY VOTES

Combines 6 wordings of this item as funds reported it.

99.7% fund support · no official result

FOR 99.6%

The 78 asset managers below cast 99.7% of the shares they voted on this item FOR (748,567 for, 2,109 against).

FOR: 748,567 (99.7%)AGAINST: 2,109 (0.3%)NOT VOTED: 431 (0.1%)
Largest asset managers voting on “To approve, by advisory vote, the Company's executive compensation program.” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BRANDES INVESTMENT PARTNERS, LP181,9730 00For
BlackRock151,6530 00For
RICE HALL JAMES & ASSOCIATES, LLC68,9190 00For
Datum One Series Trust64,4270 00For
SEI55,1150 00For
Northern Trust30,5550 00For
ISTHMUS PARTNERS, LLC26,5760 00For
Cardinal Capital Management21,5990 00For
Charles Schwab20,9530 00For
Russell Investments20,1830 00For
ADVISORS SERIES TRUST15,3430 00For
CLEARWATER INVESTMENT TRUST9,9270 00For
MARSHALL WACE, LLP7,9650 00For
LPL Financial LLC6,4220 00For
LSV ASSET MANAGEMENT5,147915 00For
QUANTITATIVE MASTER SERIES LLC5,7850 00For
FORUM FUNDS II4,9380 00For
ETF Series Solutions4,6900 00For
MERCER GLOBAL ADVISORS INC /ADV4,3720 00For
Penobscot Investment Management Company, Inc.4,0000 00For
Universal-Investment-Gesellschaft mbH3,3090 00For
RBB FUND, INC.2,6280 00For
Kovitz Investment Group Partners, LLC2,5150 00For
MACKENZIE FINANCIAL CORP2,3570 00For
Metis Global Partners, LLC2,0010 00For

Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.

2. To hold an advisory vote on the Company's executive compensation program.

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

99% fund support · no official result

FOR 99%

The 77 asset managers below cast 99% of the shares they voted on this item FOR (1,297,826 for, 17,168 against).

FOR: 1,297,826 (98.7%)AGAINST: 17,168 (1.3%)
Largest asset managers voting on “To hold an advisory vote on the Company's executive compensation program.” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Renaissance194,2130 00For
Dimensional181,6240 00For
Vanguard177,5760 00For
GEODE CAPITAL MANAGEMENT, LLC100,5210 00For
Fidelity93,6910 00For
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC83,3700 00For
State Street77,3250 00For
Royce41,9580 00For
Two Sigma36,1930 00For
HOTCHKIS & WILEY FUNDS /DE/25,9000 00For
Citadel25,8840 00For
Huber Capital Management LLC21,6360 00For
WisdomTree21,4630 00For
Columbia Threadneedle17,8000 00For
American Century016,942 00Against
T. Rowe Price16,7280 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC15,5830 00For
Principal14,1000 00For
Newton Investment Management North America, LLC13,3940 00For
Prudential/PGIM12,4970 00For
Victory Capital11,8700 00For
MELLON INVESTMENTS Corp10,5000 00For
Equitable10,2970 00For
Nuveen8,8890 00For
TIAA8,8390 00For

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

3. To elect one director to serve a term expiring at the 2028 Annual Meeting and until a successor is elected and qualified: Carrie Leigh

DIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

11%ABSTAIN 89%

The 59 asset managers below cast 100% of the shares they voted on this item FOR (96,397 for, 0 against).

FOR: 96,397 (11.0%)ABSTAIN: 779,220 (89.0%)
Largest asset managers voting on “To elect one director to serve a term expiring at the 2028 Annual Meeting and until a successor is elected and” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 174,3040Abstain
Dimensional00 165,2310Abstain
Fidelity00 92,1900Abstain
BlackRock00 84,8110Abstain
Datum One Series Trust00 64,4270Abstain
Royce40,9460 00For
SEI00 27,5350Abstain
HOTCHKIS & WILEY FUNDS /DE/00 25,9000Abstain
WisdomTree21,4630 00For
Columbia Threadneedle17,8000 00For
ADVISORS SERIES TRUST00 15,3430Abstain
Principal00 14,1000Abstain
Prudential/PGIM00 12,4970Abstain
Charles Schwab00 10,3980Abstain
Equitable5,1000 5,1970Abstain
CLEARWATER INVESTMENT TRUST00 9,9270Abstain
TIAA00 8,8390Abstain
American Century00 8,4710Abstain
Russell Investments00 7,1700Abstain
QUANTITATIVE MASTER SERIES LLC00 5,7850Abstain
Empower00 5,7000Abstain
State Street10 5,1330Abstain
BRIDGEWAY FUNDS INC00 5,0000Abstain
FORUM FUNDS II4,9380 00For
ETF Series Solutions00 4,6900Abstain

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

4. To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year ending December 31, 2025; and

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 35 asset managers below cast 100% of the shares they voted on this item FOR (622,175 for, 0 against).

FOR: 622,175 (100.0%)
Largest asset managers voting on “To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year e” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard174,3040 00For
Dimensional165,2310 00For
Fidelity92,1900 00For
Royce40,9460 00For
HOTCHKIS & WILEY FUNDS /DE/25,9000 00For
WisdomTree21,4630 00For
Columbia Threadneedle17,8000 00For
Principal14,1000 00For
Prudential/PGIM12,4970 00For
Equitable10,2970 00For
TIAA8,8390 00For
American Century8,4710 00For
State Street5,1340 00For
BRIDGEWAY FUNDS INC5,0000 00For
Northern Trust3,8970 00For
Lincoln Financial2,7850 00For
Goldman Sachs2,3910 00For
Invesco1,6740 00For
AIG/SunAmerica1,6170 00For
Brighthouse1,2930 00For
Legg Mason1,0120 00For
ProShares8730 00For
Pacific Life7710 00For
SA FUNDS INVESTMENT TRUST6300 00For
Nationwide6280 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

5. To ratify the selection of Haynie & Co. as the Company's independent registered public accounting firm for the year ending December 31, 2025.

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 24 asset managers below cast 100% of the shares they voted on this item FOR (247,742 for, 0 against).

FOR: 247,742 (100.0%)
Largest asset managers voting on “To ratify the selection of Haynie & Co. as the Company's independent registered public accounting firm for the” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock84,8110 00For
Datum One Series Trust64,4270 00For
SEI27,5350 00For
ADVISORS SERIES TRUST15,3430 00For
Charles Schwab10,3980 00For
CLEARWATER INVESTMENT TRUST9,9270 00For
Russell Investments7,1700 00For
QUANTITATIVE MASTER SERIES LLC5,7850 00For
FORUM FUNDS II4,9380 00For
ETF Series Solutions4,6900 00For
Global X1,9000 00For
JPMorgan1,8090 00For
John Hancock1,3480 00For
RBC FUNDS TRUST1,3000 00For
Jackson National1,1600 00For
Bridge Builder Trust1,0620 00For
TETON WESTWOOD FUNDS1,0000 00For
NORTHERN LIGHTS FUND TRUST II9400 00For
Nationwide5700 00For
NEW COVENANT FUNDS5150 00For
WILSHIRE MUTUAL FUNDS INC4980 00For
Gabelli3000 00For
Allianz2270 00For
Harbor ETF Trust890 00For

6. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (73,478 for, 0 against).

FOR: 73,478 (100.0%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Utah Medical Products, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
JPMorgan66,2580 00For
Empower5,7000 00For
ALGERT GLOBAL LLC1,5200 00For

Largest Utah Medical Products, Inc. shareholders voting in 2024-2025

Ranked by the number of Utah Medical Products, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 3,281,816 shares outstanding at the time of that meeting.

Top Utah Medical Products, Inc. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1BRANDES INVESTMENT PARTNERS, LP 5.54%
2BlackRock 4.62%
3RICE HALL JAMES & ASSOCIATES, LLC 2.10%
4Datum One Series Trust 1.96%
5SEI 1.68%
6Northern Trust 0.93%
7ISTHMUS PARTNERS, LLC 0.81%
8Cardinal Capital Management 0.66%
9Charles Schwab 0.65%
10Russell Investments 0.61%

Reported Utah Medical Products, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Utah Medical Products, Inc. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
BRANDES INVESTMENT PARTNERS, LP 13.70% 13G
Renaissance Technologies 6.63% 13F
Dimensional Fund Advisors 5.88% 13F
Vanguard Group 5.37% 13F
BlackRock 4.90% 13F
Geode Capital 3.28% 13F
FMR LLC 2.81% 13G
State Street 2.44% 13F
JPMorgan Chase 2.20% 13F
BNY Mellon 1.48% 13F

Percentages above are of 3,281,816 shares outstanding, as reported by Utah Medical Products, Inc. on its Form 10-K dated 2025-03-25 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Utah Medical Products, Inc.’s 10-K dated 2025-03-25. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Utah Medical Products, Inc.'s shareholder meeting held 2025-05-02, in the 2024-2025 proxy season, 154 asset managers reported how they voted in their SEC Form N-PX filings, covering 596 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, by advisory vote, the Company's executive compensation program. — the reporting funds cast 99.7% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Utah Medical Products, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.